High-resolution maps of enhancer–promoter interactions in rare primary human T cell subsets and coronary artery smooth muscle cells link variants associated with autoimmune and cardiovascular diseases to target genes. This represents an important step forward for mapping genes involved in complex diseases.
This is a preview of subscription content, log in via an institution to check access.
References
Welter, D. et al. Nucleic Acids Res. 42, D1001–D1006 (2014).
Glinos, D.A. et al. Immunology http://dx.doi.org/10.1111/imm.12796 (2017).
Mumbach, M.R. et al. Nat. Genet. 49, 1602–1612 (2017).
Pombo, A. & Dillon, N. Nat. Rev. Mol. Cell Biol. 16, 245–257 (2015).
Mumbach, M.R. et al. Nat. Methods 13, 919–922 (2016).
Farh, K.K. et al. Nature 518, 337–343 (2015).
Trynka, G. et al. Nat. Genet. 45, 124–130 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Trynka, G. Enhancers looping to target genes. Nat Genet 49, 1564–1565 (2017). https://doi.org/10.1038/ng.3982
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3982
- Springer Nature America, Inc.
This article is cited by
-
Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk
Nature Communications (2023)